Literature DB >> 12805471

Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.

Anja Ehrhardt1, Hui Xu, Mark A Kay.   

Abstract

Previously we showed that recombinant adenoviral helper-dependent (HD) vectors result in long-term transgene expression levels in vivo which slowly declined by 95% over a period of 1 year. In this study, we further establish that this was not predominantly immune mediated. To determine if cell turnover was responsible for the loss of transgene expression, we induced rapid hepatocyte cell cycling in mouse liver, by performing a surgical two-thirds partial hepatectomy. We observed a 55 and 65% reduction in transgene expression levels and a 50 and 71% loss of vector genomes for the HD vector and the first-generation adenoviral vector. In sharp contrast, in nonviral, episomal plasmid DNA-injected mice, transgene expression levels and DNA copy numbers decreased by 95 and 99%, respectively. These findings suggest that cell division alone was not the primary reason for the slow decrease in transgene expression levels and that recombinant adenoviral vectors have a more robust mechanism for maintaining persistence during cell cycling. Several potential mechanisms are proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805471      PMCID: PMC164819          DOI: 10.1128/jvi.77.13.7689-7695.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix.

Authors:  A Baiker; C Maercker; C Piechaczek; S B Schmidt; J Bode; C Benham; H J Lipps
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

2.  The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

Authors:  A Lieber; C Y He; L Meuse; D Schowalter; I Kirillova; B Winther; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Subdomain structure of the matrix attachment region located within the mouse immunoglobulin kappa gene intron.

Authors:  S Okada; K Tsutsui; K Tsutsui; S Seki; T Shohmori
Journal:  Biochem Biophys Res Commun       Date:  1996-05-15       Impact factor: 3.575

4.  Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo.

Authors:  S C Wadsworth; H Zhou; A E Smith; J M Kaplan
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Efficient lentiviral transduction of liver requires cell cycling in vivo.

Authors:  F Park; K Ohashi; W Chiu; L Naldini; M A Kay
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.

Authors:  N Morral; W O'Neal; K Rice; M Leland; J Kaplan; P A Piedra; H Zhou; R J Parks; R Velji; E Aguilar-Córdova; S Wadsworth; F L Graham; S Kochanek; K D Carey; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Cellular immune responses of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector.

Authors:  B G Harvey; S Worgall; S Ely; P L Leopold; R G Crystal
Journal:  Hum Gene Ther       Date:  1999-11-20       Impact factor: 5.695

8.  Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro.

Authors:  J N Fredman; J A Engler
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Authors:  M Lusky; M Christ; K Rittner; A Dieterle; D Dreyer; B Mourot; H Schultz; F Stoeckel; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

10.  Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.

Authors:  D Barr; J Tubb; D Ferguson; A Scaria; A Lieber; C Wilson; J Perkins; M A Kay
Journal:  Gene Ther       Date:  1995-03       Impact factor: 5.250

View more
  35 in total

Review 1.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

2.  Establishment of a High-Yield Recombinant Adeno-Associated Virus/Human Bocavirus Vector Production System Independent of Bocavirus Nonstructural Proteins.

Authors:  Ziying Yan; Wei Zou; Zehua Feng; Weiran Shen; Soo Yeun Park; Xuefeng Deng; Jianming Qiu; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2019-01-31       Impact factor: 5.695

3.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

Review 4.  Targeted gene insertion for molecular medicine.

Authors:  Katrin Voigt; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  J Mol Med (Berl)       Date:  2008-07-08       Impact factor: 4.599

5.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 6.  Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.

Authors:  Nicola Brunetti-Pierri; Philip Ng
Journal:  Virus Genes       Date:  2017-06-07       Impact factor: 2.332

Review 7.  Helper-dependent adenoviral vectors in experimental gene therapy.

Authors:  Alicja Józkowicz; Józef Dulak
Journal:  Acta Biochim Pol       Date:  2005-08-04       Impact factor: 2.149

8.  Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector.

Authors:  Gabriele Toietta; Viraj P Mane; Wilma S Norona; Milton J Finegold; Philip Ng; Antony F McDonagh; Arthur L Beaudet; Brendan Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

9.  Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements.

Authors:  Changyu Zheng; Joseph M Vitolo; Weitian Zhang; Fumi Mineshiba; John A Chiorini; Bruce J Baum
Journal:  Mol Ther       Date:  2008-03-25       Impact factor: 11.454

10.  Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

Authors:  Anurag Sharma; Dinesh S Bangari; Manish Tandon; Aseem Pandey; Harm HogenEsch; Suresh K Mittal
Journal:  Virology       Date:  2009-02-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.